PL4009942T3 - Związek służący do leczenia skojarzonego - Google Patents

Związek służący do leczenia skojarzonego

Info

Publication number
PL4009942T3
PL4009942T3 PL20751149.4T PL20751149T PL4009942T3 PL 4009942 T3 PL4009942 T3 PL 4009942T3 PL 20751149 T PL20751149 T PL 20751149T PL 4009942 T3 PL4009942 T3 PL 4009942T3
Authority
PL
Poland
Prior art keywords
compound
combination treatment
treatment
combination
Prior art date
Application number
PL20751149.4T
Other languages
English (en)
Inventor
Ulf Simonsen
Simon COMERMA-STEFFENSEN
Dan Peters
Original Assignee
Initiator Pharma A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Initiator Pharma A/S filed Critical Initiator Pharma A/S
Publication of PL4009942T3 publication Critical patent/PL4009942T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
PL20751149.4T 2019-08-06 2020-08-06 Związek służący do leczenia skojarzonego PL4009942T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19190224 2019-08-06
PCT/EP2020/072092 WO2021023805A1 (en) 2019-08-06 2020-08-06 Compound for combination treatment

Publications (1)

Publication Number Publication Date
PL4009942T3 true PL4009942T3 (pl) 2024-04-08

Family

ID=67551141

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20751149.4T PL4009942T3 (pl) 2019-08-06 2020-08-06 Związek służący do leczenia skojarzonego

Country Status (16)

Country Link
US (1) US20220288052A1 (pl)
EP (2) EP4241839A3 (pl)
JP (1) JP2022544463A (pl)
KR (1) KR20220054593A (pl)
CN (1) CN114430679A (pl)
AU (1) AU2020326244A1 (pl)
BR (1) BR112022002169A2 (pl)
CA (1) CA3146837A1 (pl)
DK (1) DK4009942T3 (pl)
ES (1) ES2962648T3 (pl)
FI (1) FI4009942T3 (pl)
IL (1) IL290319B2 (pl)
MX (1) MX2022000356A (pl)
PL (1) PL4009942T3 (pl)
WO (1) WO2021023805A1 (pl)
ZA (1) ZA202200723B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024146892A1 (en) * 2023-01-03 2024-07-11 Initiator Pharma A/S Compound for treatment of erectile dysfunction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1545552B1 (en) * 2002-06-20 2007-03-28 H. Lundbeck A/S Combination therapy wherein a serotonin reuptake inhibitor is used
MXPA05013196A (es) * 2003-07-11 2006-03-09 Elbion Ag Metodo para tratar o evitar trastornos del sistema nervioso central con compuestos que tienen selectividad por la subunidad alfa 3 del receptor de benzodiazepina.
RU2382040C2 (ru) * 2004-09-30 2010-02-20 НьюроСёрч А/С Новые хромен-2-оновые производные и их применение в качестве ингибиторов обратного захвата моноаминовых нейромедиаторов
US20090312364A1 (en) * 2006-12-20 2009-12-17 Neurosearch A/S Novel chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
RU2011105284A (ru) * 2008-08-21 2012-09-27 Ньюросерч А/С (DK) Лечение тревожных растройств
WO2011092061A1 (en) * 2010-01-29 2011-08-04 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Also Published As

Publication number Publication date
BR112022002169A2 (pt) 2022-06-07
FI4009942T3 (fi) 2023-09-26
EP4241839A2 (en) 2023-09-13
IL290319B2 (en) 2023-06-01
AU2020326244A1 (en) 2022-03-17
ZA202200723B (en) 2022-08-31
WO2021023805A1 (en) 2021-02-11
EP4009942A1 (en) 2022-06-15
EP4241839A3 (en) 2023-11-15
CA3146837A1 (en) 2021-02-11
IL290319A (en) 2022-04-01
ES2962648T3 (es) 2024-03-20
DK4009942T3 (da) 2023-10-23
EP4009942B1 (en) 2023-08-09
MX2022000356A (es) 2022-05-11
CN114430679A (zh) 2022-05-03
KR20220054593A (ko) 2022-05-03
US20220288052A1 (en) 2022-09-15
JP2022544463A (ja) 2022-10-19

Similar Documents

Publication Publication Date Title
GB201905721D0 (en) Compounds
GB201916915D0 (en) Compounds
GB201910305D0 (en) Compounds
IL290319A (en) Compound for combined treatment
GB201908536D0 (en) Compounds
GB201908171D0 (en) Compounds
GB201914296D0 (en) Treatment
GB201910304D0 (en) Compounds
GB201908095D0 (en) Carboxy-MIDA-boronate compounds
HUE062594T2 (hu) Vakolatkezelõ anyag
GB201917891D0 (en) Compounds
GB201917893D0 (en) Compounds
GB201917895D0 (en) Compounds
GB201916847D0 (en) Compounds
GB201916595D0 (en) Compounds
GB201916597D0 (en) Compounds
GB201916572D0 (en) Compounds
GB201916142D0 (en) Compounds
GB201914208D0 (en) Compounds
GB201913633D0 (en) Compounds
GB201913541D0 (en) Compounds
GB201912760D0 (en) Treatment
GB201912850D0 (en) Compounds
GB201912365D0 (en) Treatment
GB201912335D0 (en) Treatment